An internally validated new clinical and inflammation-based prognostic score for patients with advanced hepatocellular carcinoma treated with sorafenib
Crossref DOI link: https://doi.org/10.1007/s12094-017-1720-4
Published Online: 2017-08-11
Published Print: 2018-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Diaz-Beveridge, R. http://orcid.org/0000-0003-3719-7014
Bruixola, G.
Lorente, D.
Caballero, J.
Rodrigo, E.
Segura, Á.
Akhoundova, D.
Giménez, A.
Aparicio, J.
License valid from 2017-08-11